239 results
8-K
EX-99.1
DRRX
Durect Corp
30 Apr 24
Other Events
2:30pm
for the AHFIRM Trial. Reflecting the life-threatening nature of AH and the lack of therapeutic options, the U.S. Food and Drug Administration (FDA
8-K
EX-99.1
DRRX
Durect Corp
27 Mar 24
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:15pm
, the Company announced topline data for the AHFIRM Trial, as discussed above. Reflecting the life-threatening nature of AH and the lack of therapeutic options
8-K
EX-99.1
DRRX
Durect Corp
13 Nov 23
DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
4:15pm
. The Company enrolled patients at clinical trial sites across the U.S., EU, U.K., and Australia. Reflecting the life-threatening nature of AH
8-K
EX-99.1
12mim5v9ry9q8hqji0p
7 Nov 23
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial
4:10pm
8-K
EX-99.1
ydxli6xmvlg0o8 rj
7 Sep 23
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial
9:02am
8-K
EX-99.1
fy9pr1 b4ceogbru8b65
9 Aug 23
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
4:23pm
8-K
havkqaems
21 Jul 23
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
8-K
EX-10.1
5g4o9t2ub9 cdkwi
21 Jul 23
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
424B5
vobp95ab1nx18kt3dp
21 Jul 23
Prospectus supplement for primary offering
10:38am
8-K
EX-99.1
qd3aunrn7s560nt
7 Jun 23
DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis
9:00am
8-K
EX-99.1
fzlkmw1edqgmwh
16 May 23
Regulation FD Disclosure
12:08pm
8-K
EX-99.1
ryutu4a9qwtmwnba
8 May 23
DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update
4:15pm
8-K
EX-99.1
ats0v347lfrd3z
10 Apr 23
Company on track to report data from ongoing Phase 2b AHFIRM trial in 2H 2023
9:30am
8-K
EX-99.1
nyuqanqt98ly6k1lw1
2 Nov 22
DURECT Corporation Reports Third Quarter 2022 Financial Results and Update of Programs
4:16pm